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Main Points 
• Activation of Piezo1 channels in LPS-stimulated astrocytes induces calcium influx 
and augments intracellular calcium oscillations 
• Piezo1 activation inhibits the release of pro-inflammatory cytokines, IL-1β and 
TNFα, from LPS-stimulated astrocytes 
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Abstract 
Astrocytes are important for information processing in the brain and they achieve 
this by fine-tuning neuronal communication via continuous uptake and release of 
biochemical modulators of neurotransmission and synaptic plasticity. Often 
overlooked are their important functions in mechanosensation. Indeed, astrocytes 
can detect pathophysiological changes in the mechanical properties of injured, 
ageing or degenerating brain tissue. We have recently shown that astrocytes 
surrounding mechanically-stiff amyloid plaques upregulate the mechanosensitive 
ion channel, Piezo1. Moreover, ageing transgenic rats harbouring a chronic 
peripheral bacterial infection displayed enhanced Piezo1 expression in amyloid 
plaque-reactive astrocytes of the hippocampus and cerebral cortex. Here, we have 
shown that the bacterial endotoxin, lipopolysaccharide (LPS), also upregulates 
Piezo1 in primary mouse cortical astrocyte cultures in vitro. Activation of Piezo1, 
via the small molecule agonist Yoda1, enhanced Ca2+ influx in both control and 
LPS-stimulated astrocytes. Moreover, Yoda1 augmented intracellular Ca2+ 
oscillations but decreased subsequent Ca2+ influx in response to adenosine 
triphosphate (ATP) stimulation. Neither blocking nor activating Piezo1 affected cell 
viability. However, LPS-stimulated astrocyte cultures exposed to the Piezo1 
activator, Yoda1, migrated significantly slower than reactive astrocytes treated with 
the mechanosensitive channel-blocking peptide, GsMTx4. Furthermore, our data 
show that activating Piezo1 channels inhibits the release of cytokines and 
chemokines, such as IL-1β, TNFα and fractalkine (CX3CL1), from LPS-stimulated 
astrocyte cultures. Taken together, our results suggest that astrocytic Piezo1 
upregulation may act to dampen neuroinflammation and could be a useful drug 
target for neuroinflammatory disorders of the brain.  
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Introduction 
Astrocytes are the most abundant glial cell type in the brain and form interconnected 
neuron-glial networks that are exquisitely sensitive sensors and modulators of 
neuronal activity (Copeland et al., 2017; Fellin et al., 2004; Serrano, Haddjeri, 
Lacaille, & Robitaille, 2006). Astrocytes are also highly mechanosensitive cells 
(Blumenthal, Hermanson, Heimrich, & Shastri, 2014; Moshayedi et al., 2010) and 
can detect changes in the mechanical properties of their surrounding 
microenvironment during disease of the central nervous system (CNS) or following 
traumatic injury (Maneshi, Sachs, & Hua, 2015; Moshayedi et al., 2014). We have 
recently shown that astrocytes which wrap and engulf stiff amyloid plaques in the 
ageing rat brain upregulate expression of the mechanosensitive ion channel, Piezo1 
(Velasco-Estevez et al., 2018). Piezo1 is a non-selective cation channel expressed 
on the outer cell membrane and is permeable to extracellular calcium (Ca2+) influx 
(Gottlieb & Sachs, 2012; Li et al., 2015). The calcium-mediated 
mechanotransduction signalling cascades activated by Piezo1 channel opening are 
important in a range of developmental and physiological processes including 
neuronal differentiation (Pathak et al., 2014), axon guidance (Koser et al., 2016), 
confinement-sensing and cell migration (Hung et al., 2016), neuronal regeneration 
(Song et al., 2019), shear stress-mediated vasodilation (Wang et al., 2016), and 
immune cell activation (Liu et al., 2018). However, the intracellular molecular 
mechanisms that underlie Piezo1’s role in many of the above cellular processes 
have yet to be fully elucidated. McHugh et al. (2010) have also shown that Piezo1 
channels localise to the endoplasmic reticulum (ER) in epithelial cells where they 
can regulate integrin-mediated cell adhesion via calpain and talin activation. 
Therefore, Piezo1 channels can regulate intracellular Ca2+ concentrations via Ca2+ 
release from intracellular stores or through the formation of mechanically-gated ion 
channels in the outer cell membrane (Nourse & Pathak, 2017). Interestingly, Piezo1 
is also voltage sensitive (Moroni, Servin-Vences, Fleischer, Sanchez-Carranza, & 
Lewin, 2018) and, therefore, its repertoire of known functions in CNS neurons and 
glial cells, both in health and disease, is likely to increase in the near future. 
 
In endothelial cells, shear stress activates Piezo1-mediated Ca2+ influx leading to 
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the release of adenosine triphosphate (ATP) (Wang et al., 2016). In turn, ATP can 
activate purinergic G protein-coupled receptors, such as P2Y1 and P2Y2, on 
neighbouring cells causing the upregulation of nitric oxide synthase (NOS) (Jacob, 
Perez Novo, Bachert, & Van Crombruggen, 2013). Nitric oxide (NO) release from 
astrocytes acts as an important neuromodulator in the brain and can induce further 
gliotransmitter release, including glutamate (Bal-Price, Moneer, & Brown, 2002). 
ATP and glutamate have a wide range of functions at the synapse and can initiate 
Ca2+ oscillations and Ca2+ waves in astrocytes (Leybaert & Sanderson, 2012; 
Scemes & Giaume, 2006), thus modulating long-range communication and 
information processing through astrocyte-neuron networks. ATP can also regulate 
the release of neuromodulators from astrocytes, such as cytokines that fine-tune 
local neurotransmission and synaptic plasticity processes (Adzic et al., 2017; 
Nishizaki, 2004). Interestingly, astrocytic Piezo1 expression was relatively high in 
the cortex and hippocampus of transgenic Alzheimer’s rats (TgF344-AD) that 
harboured a chronic urinary tract infection (UTI) of Escherichia coli (E. coli). This 
suggests that raised levels of cytokines, chemokines and neuroinflammation, which 
often develops in the elderly as a result of chronic peripheral immune activation 
(Chesnokova, Pechnick, & Wawrowsky, 2016; Simen, Bordner, Martin, Moy, & 
Barry, 2011), may lead to the enhanced expression of Piezo1 in amyloid plaque-
reactive astrocytes (Velasco-Estevez et al., 2018). However, whether this 
upregulation of mechanosensitive Ca2+ permeable channels in the ageing 
Alzheimer’s disease brain is neuroprotective, or instead enhances neuro-damaging 
signalling cascades, is as yet unknown. 
 
Here, we used an in vitro murine-derived primary astrocyte culture model to 
examine the effects of activating Piezo1 on several key functional parameters 
including, 1) cytosolic Ca2+ oscillations, 2) ATP-induced Ca2+ influx, 3) astrocyte 
migration, and 4) cytokine and chemokine release from control and LPS-stimulated 
astrocyte cultures. The aim was to investigate if upregulation of Piezo1 in reactive 
astrocytes exacerbates neuroinflammation or whether Piezo1 expression in LPS-
stimulated astrocytes could be an innate neuroprotective response to disease 
pathogenesis in the inflamed brain.  
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Materials and Methods  
 
Ethics statement 
All experiments involving animals, and Schedule 1 protocols used to obtain brain 
tissue, were approved by the Animal Welfare and Ethical Review Bodies (AWERB 
committees) of the University of Brighton and Trinity College Dublin. This study 
was conducted in accordance with the principles of the Basel Declaration and 
adhered to the legislation detailed in the UK Animals (Scientific Procedures) Act 
1986 Amendment Regulations (SI 2012/3039). All efforts were taken to maximise 
animal welfare conditions and to reduce the number of animals used in accordance 
with the European Communities Council Directive of September 20th, 2010 
(2010/63/EU). 
 
Mouse cortical astrocyte cultures 
Mixed glial cell cultures were prepared from cerebral cortical tissue from postnatal 
day one (P1) male and female wild-type C57BL/6 mice (RRID: 
IMSR_JAX:000664) bred in the BioResources Units of Trinity College Dublin and 
the University of Brighton. Two mouse cortices were used per T75 flask 
preparation. Mixed glial cells were cultured at 37oC and 5% CO2 in a humidified 
incubator for 14 days in Dulbecco’s modified Eagle’s medium/F12 (DMEM/F12; 
Hyclone SH30023) supplemented with 10% foetal bovine serum (FBS; Labtech, 
FB-1090) and 1% penicillin/streptomycin (Sigma, P4333), as previously described 
(Healy et al., 2013; O'Sullivan, Velasco-Estevez, & Dev, 2017). After 14 days in 
vitro (DIV), T75 flasks containing confluent glial cell cultures were shaken for 2 h 
at 200 rpm using an orbital shaker (VWR, Microplate shaker Model No. 
980131UK) to eliminate most of the microglia and oligodendrocytes from the glial 
monolayer. The remaining enriched astrocyte culture was exposed to 0.5% trypsin 
for 5 min to cause detachment of the glial monolayer and cells were then re-plated 
in a new T75 flask to further purify the astrocyte culture and eliminate loosely 
attached microglia. Once the re-plated cells were 80% confluent, they were again 
exposed to 0.5% trypsin, detached and re-plated in different cell culture substrates 
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for the various experiments described below. Using this method, enriched astrocyte 
cultures are >95% pure, as previously described (Healy et al., 2013). 
 
Immunocytochemistry 
After each pharmacological treatment, cells were fixed in 10% formalin solution 
(Sigma, F1635) for 5 min on ice. Cells were blocked for 18 h at 4oC in blocking 
solution containing 1% bovine serum albumin (BSA; Santa-Cruz, sc-2323) and 
0.1% Triton X-100 (Sigma, T8787). Primary antibodies were diluted in blocking 
solution and incubated for 18 h at 4oC. Cells were washed with PBS containing 
0.1% Triton X-100 followed by incubation with secondary antibodies diluted in 
blocking solution at 22oC for one hour in the dark. After several washes, coverslips 
were mounted on a microscope slide (Clarity, C361) with antifade reagent 
(ThermoFisher, S36936). Primary antibodies used were: Piezo1 (Abcam, 
ab128245; RRID: AB_11143245; rabbit polyclonal, dilution 1/500) and GFAP 
(Abcam, ab4674; RRID: AB_304558; chicken polyclonal, dilution 1/1,000). 
Secondary antibodies used were biotinylated anti-rabbit (ThermoFisher, A24535; 
RRID: AB_2536003; dilution 1/1,000), avidin Alexa® 488 conjugate 
(ThermoFisher, A21370; dilution 1/1,000) and Alexa® 633 anti-chicken (Alexa, 
A21103; RRID: AB_2535756; dilution 1/1,000). Imaging was performed using a 
Leica TCS SP8 confocal microscope.  
 
Quantitative Reverse-transcription PCR (RT-qPCR) 
RNA extraction was performed using the RNeasy mini kit (QIAGEN, #74104), 
following the manufacturer’s instructions. The quantity and quality of mRNA was 
measured by spectrophotometric analysis using a nanodrop (ThermoFisher, 
NanoDropTM One/Onec microvolume). RNA concentration was quantified using 
the optical density (OD) at 260 nm. The 260/280 nm ratios were used as a measure 
of quality and only samples with values between 1.8 – 2.0 were considered 
acceptable. Reverse transcription of the mRNA was performed using the 
QuantiNova Reverse Transcription Kit (QIAGEN, #205411) in a 3Prime 
thermocycler (TECHNE, 3PRIMEG/02, serial no. *32288*). The PCR master mix 
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was obtained by mixing SYBR green dye (QIAGEN, #1054596), Quantitect® 
Primer of mouse Piezo1 (Mm_Piezo1_3_SG; QT01199142) or β-actin 
(Mm_Actb_1_SG; QT00095242) and the cDNA template. The reaction was 
performed in a Rotor-Gene Q 5plex (QIAGEN, #90158) with PCR cycles of 
denaturation at 95oC for 5 seconds and annealing/extension at 60oC for 10 seconds, 
40 times.  
 
Western-Blot 
Mouse astrocyte protein samples were obtained by scraping the cell monolayer in 
RIPA buffer. Samples were run in a 6% SDS-PAGE electrophoresis gel and 
transferred to PVDF membranes (Millipore, IPVH00010) by wet transfer (buffer 
composition: 2.5 mM Tris, 19.2 mM Glycine and 5% methanol, pH 8.3) at constant 
70 V for 3 h on ice. Membranes were then blocked in PBS containing 5% BSA and 
0.05% Tween-20 for 2 h at 22oC and incubated with primary antibodies that 
recognise Piezo1 (Abcam, ab128245; RRID: AB_11143245; dilution 1/300 in 
blocking buffer) or α-actin (Abcam, ab3280; RRID: AB_303668; dilution 1/2,000 
in blocking buffer) for 18 h at 4oC. After several PBS and PBS-Tween 0.05% 
washes, membranes were incubated with a goat anti-rabbit HRP-conjugated 
secondary antibody (GE Healthcare, NA934; RRID: AB_772206; dilution 1/5,000 
in blocking buffer) or goat anti-mouse secondary antibody (Sigma, A8924; RRID: 
AB_258426; dilution 1/5,000 in blocking buffer) for 2 h at 22oC. Several washes 
were then performed and PVDF membranes were developed using a 
chemiluminescent HRP substrate (Millipore, WBKLS0500). 
 
MTT assay 
Astrocytes were seeded in 96-well plates (Corning) at a density of 15,000 cells/well 
and grown for 48 h in DMEM/F12 medium containing 10% FBS. They were then 
serum-starved for 3 h prior to stimulation with LPS (100 ng/ml) alone or in 
combination with GsMTx4 (500 nM) or Yoda1 (10 µM) for 48 h. Following each 
treatment, the cell culture medium was removed and stored for ELISA assays and 
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replaced with 100 µL of fresh medium supplemented with 1 mg/mL 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Invitrogen, 
M6494) for 3 h at 37°C. Next, 75 µL of culture medium was removed and 50 µL 
of dimethyl sulfoxide (DMSO) was added. Astrocytes were incubated for 10 min at 
37°C and the absorbance in each well was read at a wavelength of 540 nm. 
 
JC-1 assay 
Changes in mitochondrial potential were measured using a commercially available 
JC-1 assay kit (Abcam, ab113850) following the manufacturer’s instructions. 
Briefly, astrocytes were seeded in a 96-well plate at a density of 15,000 cells/well 
and treated as described above for the MTT assay. 30 min prior to the end of each 
treatment, 10 µM JC-1 dye was added to each well at a final concentration of 5 µM. 
After 30 min, the wells were washed twice with dilution buffer. The excitation 
wavelength was set at 535 ± 17.5 nm and the emission at 590 ± 17.5 nm. Aggregate 
emission was measured in a BioTek synergy HT microplate reader (BioTek, VT, 
USA). 
 
ELISA assay  
Cytokine and chemokine release from astrocytes were quantified using 
commercially available duo-set ELISA kits (R&D Systems) for mouse IL-6 
(DY406), TNF-α (DY410), IL-1β/ IL-1F2 (DY401) and CX3CL1 (DY472). Briefly, 
96 well MicroWell™ MaxiSorp™ flat bottom plates (Sigma, 442404) were coated 
with the capture antibody diluted in PBS for 18 h at 4°C. Plates were then washed 
in 0.5% Tween-20 in PBS and blocked with the appropriate reagent diluent for 1 h 
at 22°C. The blocking buffer was then removed and the astrocyte culture medium 
and recombinant protein standards were diluted, added to the wells and incubated 
for 2 h at 22°C. The wells were then washed and the detection antibody was added 
for 2 h at 22°C. The detection antibody was then washed off and a solution 
containing streptavidin-HRP secondary antibody was added for 20 min and kept in 
the dark. The secondary antibody solution was washed off and the substrate solution 
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was added (DY999, R&D Systems) and incubated for 20 min. The reaction was 
stopped by adding 2N H2SO4 to the plate and absorbance was immediately read at 
450 nm with wavelength correction at 570 nm.  
 
Cell migration assay 
A 500 μm wide strip of silicone (silicone sheet of 0.0005” NRV G/G 12”x12”, 
SM11074036) was placed down the middle of each well of a 12 well-plate. 
Astrocytes were then seeded onto each well and grown in supplemented 
DMEM/F12 media until 90% confluent. Cells were then serum-starved and treated 
with 100 ng/mL LPS (Sigma, L4391) with or without 10 μM Yoda1 (Tocris, #5586) 
or 500 nM GsMTx4 (Alomone, STG-100) for 24 h. The silicone strip was then 
carefully removed and the 500 μm “wound area” was imaged at ‘time zero’ using a 
Nikon Eclipse Ti-U microscope with 10× magnification objective and a Nikon 
digital sight camera connected to the NIS-Elements BR 3.2 software package 
(Nikon, Japan). The wound area was imaged again 48 h post-silicone removal and 
the change in the width of the area containing no cells was calculated using ImageJ 
software (http://imagej.nih.gov/ij). 
 
Live-cell calcium imaging  
Astrocytes were seeded onto 25 mm tissue culture plastic coverslips (Sarstedt, 
#83.1840) in a 6 well-plate and grown for 72 h in supplemented DMEM/F12 until 
70% confluent. Cells were then serum-starved for 3 h prior to treatment with or 
without 100 ng/mL LPS for 24 h. After treatment, cells were incubated with 3 μM 
Cal-520AM dye (Abcam, ab171868) in Hank’s balanced salt solution (HBSS; no 
phenol red) supplemented with 10 mM glucose and 25 mM HEPES for 90 min at 
37oC, followed by 30 min at 22oC. Cells were protected from bright light at all 
times. Coverslips were then placed into the AttofluorTM acquisition chamber 
(Invitrogen) with supplemented HBSS or HBSS minus Ca2+ and Mg2+ (HBSS-/-). 
Time-lapse Ca2+ imaging was performed at a rate of 0.77 frames per second. 
Following a 30 second baseline, cells were stimulated with either HBSS or 10 μM 
Yoda1 for 240 seconds and stimulated further with 50 μM ATP for 180 seconds. 
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Extracellular Ca2+ imaging experiments were performed with standard HBSS and 
intracellular Ca2+ imaging experiments were performed with HBSS minus Ca2+ and 
Mg2+ (HBSS-/-). Images were acquired using a Leica SP5 confocal microscope and 
a 20× magnification objective. 
 
Calcium imaging analysis 
Time-lapse Ca2+ imaging experiments were saved as Leica .lif files and exported as 
individual RAW 8 bit .tif images (349 in total per experiment). The maximum 
intensity projection image was used to create a binary mask allowing for 
segmentation of the monolayer of astrocytes into individual cells. Image analysis 
was performed using the R programming environment and EBImage package (Pau, 
Fuchs, Sklyar, Boutros, & Huber, 2010). Two image segmentation steps were 
performed. The first identified individual astrocyte nuclei and the second was 
performed to segment the cytosol of each astrocyte from one another. Nuclear and 
cytosolic Ca2+ responses for each astrocyte were analysed separately, but both 
provided very similar results and so only the cytosolic Ca2+ imaging quantification 
is presented here. Absolute changes in cytosolic Ca2+ fluorescence intensities were 
measured for each cell over a 7 min 30 second time period and were then normalised 
to the baseline fluorescence intensity values for each cell [ΔF/F0], where F0 is the 
average fluorescence intensity of frames 5–15. This converted the absolute changes 
in cytosolic Ca2+ fluorescence intensity to relative changes in Ca2+ fluorescence per 
cell. There were four treatment groups per experiment, 1) Control/HBSS, 2) 
Control/Yoda, 3) LPS/HBSS, and 4) LPS/Yoda. Experiments were conducted 
either in the presence (Extracellular Ca2+) or absence (Intracellular Ca2+) of 
extracellular Ca2+ and Mg2+ using either Control or LPS pre-treated astrocytes. 
Extracellular Ca2+ experiments were repeated n = 8 with 3 technical replicates per 
treatment group, i.e. the Ca2+ imaging experiments were repeated on 8 separate days 
using astrocyte cultures from 8 different mouse litters and 3 x 25 mm coverslips of 
cells were imaged per group during each live-cell imaging session. Intracellular 
Ca2+ experiments were repeated n = 6 with 3 technical replicates per group. In total, 
the number of astrocytes analysed per treatment group were as follows: For 
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Extracellular Ca2+ experiments, 1) Control/HBSS = 4,286, 2) Control/Yoda = 
4,023, 3) LPS/HBSS = 3,980, and 4) LPS/Yoda = 3,915. For Intracellular Ca2+ 
experiments, Control/HBSS-/- = 3,866, 2) Control/Yoda-/- = 3,967, 3) LPS/HBSS-/- 
= 3,069, and 4) LPS/Yoda-/- = 3,290. In Figures 3 and 5, the relative changes in 
cytosolic Ca2+ fluorescence are expressed as the median value ± interquartile range 
(IQR). Moreover, the first 2 min (early) and the last 2 min (late) of HBSS or Yoda1 
perfusion are also displayed in Figures 3A and 5A as the mean change in cytosolic 
Ca2+ fluorescence ± the standard error of the mean.  
 
Statistical analysis 
All statistical analysis was performed using GraphPad Prism 7 (GraphPad Prism®, 
RRID:SCR_002798). Assessment of the normality of data was carried out using the 
column statistics function and D’Agostino criteria before any further statistical test 
was performed. When only two groups were compared, a paired Student t-test was 
performed. In cases when three or more groups needed to be compared, repeated 
measures one-way or two-way ANOVAs were performed and post-hoc tests were 
applied with p value adjustments using Bonferroni or Holm-Sidak methods. The 
analysis of proportions was carried out using chi-squared (χ2) tests in conjunction 
with the Bonferroni correction for multiple comparisons. P values < 0.05 were 
considered statistically significant. Further details of the statistical analyses 
performed are given in each figure legend and the results section.  
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Results 
 
LPS induces Piezo1 expression in cortical astrocytes 
We have recently shown in a rat model of Alzheimer’s disease (TgF344-AD) that 
hippocampal and cortical astrocytes surrounding amyloid plaques upregulate 
Piezo1 expression. Interestingly, astrocytic Piezo1 expression is enhanced in rats 
harbouring a chronic urinary tract infection with E. coli (Velasco-Estevez et al., 
2018). Here, we show that mouse cortical astrocytes exposed to lipopolysaccharide 
(LPS) upregulate Piezo1 channel expression. The Gram-negative bacterial 
endotoxin LPS induces a strong immune reaction in animals and is an agonist of 
toll-like receptor 4 (TLR4) which is expressed by mouse astrocytes (Nakano et al., 
2015). Treatment with 100 ng/mL LPS induced an inflammatory phenotype in 
primary cortical astrocytes (Fig. 1A–D) and caused an upregulation of Piezo1 
channels after 24 h (Fig. 1E). Approximately 2–3% of astrocytes expressed low 
levels of Piezo1 under non-inflammatory conditions and this rose to 20–25% of 
astrocytes after 24 h LPS exposure (Fig. 1F). Interestingly, Piezo1 expression 
(measured as immunofluorescence intensity) decreased again after 48 h exposure 
to LPS (Fig. 1E), but the proportion of cells expressing low levels of Piezo1 
remained above control (Fig. 1F). Piezo1 upregulation in astrocytes following 24 h 
exposure to LPS was confirmed by Western blot (Fig. 1G) and by PCR analysis of 
mRNA transcript levels (Fig. 1H). 
 
Piezo1 activation enhances calcium influx in LPS-stimulated astrocytes 
Piezo1 is a Ca2+ permeable cation channel and since LPS caused an increase in 
Piezo1 expression in astrocytes (Fig. 1), we next investigated the effects of Piezo1 
activation on Ca2+ influx and Ca2+ oscillations in cortical astrocytes. Astrocyte 
cultures were pre-treated either with or without LPS (100 ng/mL) for 24 h and then 
loaded with Cal-520AM calcium dye (Fig. 2A). Time-lapse Ca2+ imaging was 
performed at a rate of 0.77 frames per second. After a 30 s baseline recording (23 
frames), the Piezo1 agonist, Yoda1 (10 µM), was perfused onto non-treated 
astrocyte cultures (i.e. Control/Yoda) causing an increase in cytosolic Ca2+ 
concentration in 48% of astrocytes (i.e. 52% of cells did not respond to Yoda1). 
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Because Piezo1 channels can be activated by shear stress, HBSS was used to control 
for extracellular solution perfusion (i.e. Control/HBSS). 46% of cells responded to 
the addition of HBSS alone (i.e. showed one or more Ca2+ peaks) but the increases 
in cytosolic Ca2+ were significantly lower than for Yoda1 (Fig. 2B). Similarly, 45% 
of cells in the LPS-stimulated astrocyte cultures responded to HBSS perfusion, 
whereas 60% of cells responded to Yoda1 (χ2 test, p < 0.001) which caused much 
larger Ca2+ influxes (Fig. 2C). This was presumably due to the upregulation of 
Piezo1 channels in LPS-stimulated astrocytes (Fig. 1). 
 
The median area under the curve (AUC with arbitrary fluorescence units; a.f.u.) 
was negative in response to HBSS, i.e. -5.2 a.f.u (-36.9, +41.4 IQR) suggesting a 
small net efflux of intracellular Ca2+ (Fig. 3A). Yoda1, on the other hand, induced 
an increase in Ca2+ influx, with the median AUC measured as +48.3 a.f.u (-3.2, 
+158.1 IQR). Interestingly, for control astrocytes perfused with HBSS or Yoda1 and 
for LPS-stimulated cultures perfused with HBSS, 9 – 10% of cells responded with 
two or more Ca2+ peaks (Fig. 3B) over the 4 min time-frame. In contrast, astrocytes 
pre-treated with LPS and perfused with Yoda1 displayed a doubling (20%) in the 
proportion of cells that responded with two or more Ca2+ peaks (χ2 test, p < 0.001), 
suggesting that Piezo1 increases Ca2+ oscillations in LPS-reactive astrocytes (Fig. 
3B). 
 
Activation of Piezo1 in LPS-stimulated astrocytes modifies their 
response to ATP 
After recording control and LPS-stimulated astrocyte Ca2+ responses to both HBSS 
and Yoda1 for 4 min, all four groups of cells were then perfused with 50 µM ATP. 
Time-lapse images were captured for a further 3 min (140 frames) to determine the 
proportions of astrocytes that display ATP-induced Ca2+ oscillations. Control and 
LPS-stimulated astrocytes pre-perfused with HBSS displayed ATP-induced Ca2+ 
peaks that were larger in amplitude to those elicited by astrocytes pre-perfused with 
Yoda1 (Fig. 3C). This is because the Control/HBSS and LPS/HBSS groups 
displayed negative median AUC Ca2+ responses to HBSS perfusion and, therefore, 
had low basal Ca2+ levels upon the addition of ATP. This enabled them to respond 
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with large ATP-induced Ca2+ peaks. The LPS/HBSS group showed the largest AUC 
Ca2+ response to ATP perfusion, i.e. +151.9 a.f.u (+84.2, +225.5 IQR). Interestingly, 
astrocytes that displayed the highest number of Ca2+ oscillations to Yoda1 (i.e. the 
LPS/Yoda1 group) responded with the lowest number of Ca2+ peaks following ATP 
perfusion, i.e. 26% of astrocytes in the LPS/Yoda1 group displayed 2 or more Ca2+ 
peaks whereas 45% of the Control/HBSS group showed ATP-induced Ca2+ 
oscillations (χ2 test, p < 0.001) (Fig. 3D). Taken together, our data indicate that 
Yoda1 enhances Ca2+ oscillations in LPS-stimulated astrocytes (due to upregulation 
of Piezo1), but this increases basal Ca2+ levels and consequently reduces the 
proportion of cells that display Ca2+ oscillations in response to ATP. 
 
Piezo1 activation enhances calcium release from intracellular stores in 
LPS-stimulated astrocytes 
To determine the effects of Piezo1 activation on Ca2+ release from internal stores, 
extracellular Ca2+ and magnesium (Mg2+) were removed from the medium, i.e. 
HBSS minus Ca2+ and Mg2+ (HBSS-/-). Experiments were repeated, as above, with 
the same four groups of astrocytes, i.e. Control/HBSS-/-, Control/Yoda1-/-, 
LPS/HBSS-/- and LPS/Yoda1-/- (Fig. 4A – C). Interestingly, Yoda1-/- (dissolved in 
HBSS minus Ca2+ and Mg2+) caused a large efflux of Ca2+ from control astrocytes; 
-63.8 a.f.u (-98.6, -7.3 IQR), but LPS-stimulated astrocytes showed a net increase 
in cytosolic Ca2+ levels; +11.0 a.f.u (-50.6, +75.8 IQR) (Fig. 5A). As such, Yoda1 
increased the proportion of cells in non-treated astrocytes that displayed zero 
positive peak deflections in intracellular Ca2+ (i.e. Control/Yoda1-/- 55% vs 34% 
Control/HBSS-/-, χ2 test, p < 0.001). This was due to the large net efflux of Ca2+ to 
the extracellular medium and, therefore, the decrease in basal Ca2+ levels in the 
Control/Yoda1-/- group. However, comparable proportions of cells (24%) in the 
Control/Yoda1-/- group responded with one positive Ca2+ peak compared to 
astrocytes in the Control/HBSS-/- group (27%). Therefore, the difference lay in the 
proportion of cells that displayed Ca2+ oscillations (i.e. 2 or more peaks). 21% of 
Control/Yoda1-/- cells displayed Ca2+ oscillations in response to Yoda1 whereas 
39% of cells in the Control/HBSS-/- group showed Ca2+ oscillations following 
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HBSS-/- perfusion (Fig. 5B). This indicates that Yoda1-/- decreases Ca2+ oscillations 
driven by internal stores in control non-reactive astrocytes (χ2 test, p < 0.001). 
 
The opposite was true for the LPS/HBSS-/- group, however. A similar proportion of 
non-responders (32%) were measured in LPS/HBSS-/- treated astrocytes compared 
to 34% of cells in the Control/HBSS-/- group. However, there was a 10% increase 
in cells displaying Ca2+ oscillations (LPS/HBSS-/- 49% vs 39% Control/HBSS-/-, χ2 
test, p < 0.001), suggesting that LPS-stimulated astrocytes are more ‘responsive’ to 
shear stress and display more internal store-driven Ca2+ oscillations. Interestingly, 
Yoda1 induced a modest 4% increase in the proportion of cells that displayed Ca2+ 
oscillations in LPS-stimulated cultures (LPS/HBSS-/- 49% vs 53% LPS/Yoda1-/-, χ2 
test, p = 0.008). However, Yoda1 caused a greater increase in the proportion of cells 
that respond with just one peak in intracellular Ca2+ (LPS/HBSS-/- 19% vs 28% 
LPS/Yoda1-/-) (Fig. 5B). This increase in internal store-driven Ca2+ oscillations in 
LPS-treated astrocytes exposed to Yoda1 impacted their subsequent responses to 
ATP perfusion. As such, 68% of astrocytes in the LPS/Yoda1-/- group responded to 
ATP with one positive peak in intracellular Ca2+ versus 61% of LPS/HBSS-/- 
astrocytes (χ2 test, p < 0.001). However, this meant that 39% of LPS/HBSS-/- 
astrocytes showed ATP-induced Ca2+ oscillations versus 32% of the LPS/Yoda1-/- 
group. The proportion of cells showing Ca2+ oscillations to ATP in the 
Control/Yoda1-/- group was even lower again (24%) compared to the 
Control/HBSS-/- group (33%). Therefore, whilst Yoda1 caused an increase in ATP-
induced Ca2+ release from intracellular stores in control astrocytes (Fig. 5C) and 
increases the percentage of cells that respond with one Ca2+ peak following ATP 
perfusion (Fig. 5D), astrocyte cultures in the Control/Yoda1-/- group displayed the 
lowest proportion of cells (24%) that oscillate in response to Yoda1 perfusion (Fig. 
5D). Taken together, LPS-stimulated astrocytes respond to Yoda1 by increasing 
intracellular Ca2+ levels and internal store-driven Ca2+ oscillations compared to 
astrocytes perfused with control HBSS-/-. However, LPS/Yoda1-/- astrocytes were 
less responsive to ATP, presumably because their basal Ca2+ levels were higher than 
the Control/Yoda1-/- group. 
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Blocking Piezo1 channels enhances cell migration in LPS-stimulated 
astrocytes 
Astrocytes were treated with LPS (100 ng/mL) for 48 h in the presence or absence 
of either Yoda1 (agonist) or GsMTx4 (antagonist) to activate or inhibit Piezo1 
channels, respectively. Neither activation nor inhibition of Piezo1 affected cell 
viability (Fig. 6A) or mitochondrial stress (Fig. 6B). Because Piezo1 channels have 
been shown previously to regulate endothelial (Eisenhoffer et al., 2012), fibroblast 
(Chubinskiy-Nadezhdin et al., 2019) and cancer cell migration (McHugh, Murdoch, 
Haslett, & Sethi, 2012), we next investigated if Piezo1 channels modulate astrocyte 
migration. Control astrocytes were grown to confluency over a 500 µm silicone 
strip running down the centre of a 35 mm cell culture well. The silicone strip was 
then peeled away to create a reproducible ‘wound healing’ type assay to measure 
collective astrocyte migration velocities over a 48-hour period. Astrocytes were 
exposed to either Yoda1 (10 µM) or GsMTx4 (500 nM) for 48 h, neither of which 
had any significant effect on astrocyte migration compared to non-treated control 
cells which migrated at an average velocity of 3.3 ± 1.0 µm/h (Fig. 6C). Astrocytes 
treated with GsMTx4 migrated at 3.8 ± 0.6 µm/h but this was not statistically 
significantly faster than astrocytes treated with Yoda1 (2.0 ± 0.4 µm/h). In order to 
assess the role of Piezo1 in cell migration, astrocytes were stimulated with LPS to 
trigger Piezo1 expression and migratory velocities were monitored over 48 h. LPS-
stimulated astrocytes exposed to GsMTx4 for 48 h migrated at a velocity of 5.0 ± 
0.9 µm/h. This was not significantly faster than astrocytes treated with LPS alone 
(2.3 ± 0.3 µm/h) but was significantly faster than LPS-stimulated astrocytes 
exposed to Yoda1 (1.3 ± 0.5 µm/h) (Fig. 6C). This suggests that Piezo1 channel 
activity regulates astrocyte migration under neuroinflammatory conditions (Fig. 
6D, E). 
 
Yoda1 inhibits cytokine and chemokine release from LPS-stimulated 
astrocytes 
LPS is a well-known trigger of inflammation and cytokine release from astrocytes 
(Liddelow et al., 2017). Our next aim was to investigate if modulating Piezo1 
activity alters pro-inflammatory cytokine or chemokine release from cortical 
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astrocyte cultures. Treating astrocytes with Yoda1 for 48 h, in the presence of LPS, 
decreased the release of TNFα (484 ± 157 vs 2,046 ± 410 pg/mL) (Fig. 7A), IL-1β 
(111 ± 12 vs 515 ± 122 pg/mL) (Fig. 7B), and CX3CL1 (4,089 ± 430 vs 11,745 ± 
1,210 pg/mL) (Fig. 7D), but had no significant effect on IL-6 release (4,274 ± 601 
vs 6,468 ± 1,202 pg/mL) (Fig. 7C). However, there was a statistically significant 
difference in the amount of IL-6 released from astrocytes treated with LPS/Yoda1 
(4,274 ± 601 pg/mL) versus LPS/GsMTx4 (8,076 ± 947 pg/mL) (Fig. 7C). 
Interestingly, Yoda1 also decreased CX3CL1 release from control astrocytes (3,105 
± 94 vs 10,140 ± 741 pg/mL). Taken together, our results suggest that LPS exposure 
upregulates Piezo1 in a modest proportion of astrocytes (~25%) and, when 
activated, Piezo1 channels increase intracellular Ca2+ oscillations and inhibit the 
production and release of pro-inflammatory cytokines and chemokines (Fig. 8). 
Astrocytic Piezo1 may, therefore, act to dampen CNS neuroinflammation.  
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Discussion 
 
Our understanding of glial cell biology and biophysics has advanced rapidly over 
the last two decades and it is now widely accepted that astrocytes resident in 
different brain regions exhibit heterogeneity in morphology and function (Matias, 
Morgado, & Gomes, 2019). Local sub-populations of astrocytes within a common 
neuronal ensemble also appear to exhibit distinct functional groupings, such as the 
A1 and A2 phenotypes recently described (Liddelow et al., 2017). Astrocytes sense 
and react to the local biochemical milieu of the brain parenchyma, as well as to the 
mechanical properties of the extracellular matrix and neighbouring cells, 
particularly after CNS injury (Bowers, Fiori, Khadela, Janmey, & Galie, 2019; 
Rocha, Ferraz-Nogueira, Barrias, Relvas, & Pego, 2015). Here, primary mouse 
astrocyte cultures were used to investigate several potential functions of astroglial 
Piezo1 channels in the cerebral cortex during a neuroinflammatory stimulus. Our 
data suggest that the bacterial endotoxin, LPS, triggers Piezo1 expression in cortical 
astrocytes which normally express very low levels of mechanosensitive Piezo1 ion 
channels, at least under control conditions in vitro, although we and others have 
detected astrocytic Piezo1 expression in vivo (Choi, Sun, & Jakobs, 2015; Velasco-
Estevez et al., 2018). However, not all LPS-stimulated astrocytes (~25%) expressed 
the Piezo1 protein in vitro, suggesting those that did may have slightly different 
functions to their Piezo1-negative neighbours. Alternatively, astrocytes in culture 
may display a range of responses to LPS stimulation. For instance, the levels of 
TLR4 receptor expression may vary between functionally distinct subpopulations 
of cultured astrocytes (El-Hage et al., 2011) which could also explain why only 
~25% of astrocytes expressed Piezo1 post-LPS treatment. 
 
Astrocyte migration  
Astrocyte migration was assessed using a two-dimensional wound healing-type 
assay and, therefore, resembled an unrestricted collective cell migration. Cell 
migration can be classified using several criteria, e.g. single cell vs collective 
migration (Rorth, 2009), ameboid vs integrin-dependant (Friedl & Brocker, 2000) 
or confined vs unrestricted migration (Hung et al., 2016). In the healthy adult brain, 
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astrocytes do not generally migrate (Zhan et al., 2017). However, in 
neuroinflammatory states or following traumatic tissue injury, reactive astrocytes 
can change shape, become hypertrophic (Sofroniew & Vinters, 2010), contribute to 
glial scarring (Buffo, Rolando, & Ceruti, 2010) and display integrin-dependent 
migration (Cardenas, Kong, Alvarez, Maldonado, & Leyton, 2014). Interestingly, 
before its characterisation as a mechanosensitive ion channel, McHugh et al. (2010) 
described an important role for Piezo1 in maintaining integrin-mediated cell 
adhesion in epithelial cells. Piezo1 reportedly recruits the small GTPase, R-Ras, to 
the endoplasmic reticulum leading to release of calcium from internal stores, 
activation of calpain signalling, cleavage of talin and enhancement of integrin 
affinity, thus strengthening cell adhesions. Moreover, knocking down Piezo1 using 
siRNA increased migration of lung epithelial cells through loss of integrin-mediated 
cell adhesions (McHugh et al., 2012). Therefore, it has been suggested that Piezo1 
expression may influence the metastatic invasiveness of cancer cells (Li et al., 2015; 
Yang et al., 2014). However, Piezo1 antagonism appears to have different effects 
on migration in different cell types. Treating human umbilical vein endothelial cells 
(HUVECs) or prostate cancer cell lines (PC-3 and LNCaP) with GsMTx4 causes a 
decrease in cell migration (Li et al., 2014; Maroto, Kurosky, & Hamill, 2012) but 
enhances neurite outgrowth in Xenopus spinal cord explants (Jacques-Fricke, Seow, 
Gottlieb, Sachs, & Gomez, 2006). More recently, Song and colleagues have shown 
that Piezo1 activation can inhibit neural regeneration in Drosophila (Song et al., 
2019). Here, we show that astrocytes exposed to LPS (to induce Piezo1 expression) 
and GsMTx4 (to simultaneously block Piezo1 channel opening) migrate faster than 
astrocytes stimulated with LPS and Yoda1 (which activates Piezo1 channels). It is 
possible that GsMTx4 modulates integrin affinity in reactive astrocytes, thus 
enhancing collective cell migration velocity. In agreement with our findings, 
Chubinskiy-Nadezhdin et al. (2019) have also recently reported that Yoda1 
decreases fibroblast migratory speed. Therefore, we hypothesise that activation of 
Piezo1 may attenuate the reactive phenotype of astrocytes in vivo by dampening 
their migratory capacity in neuroinflammatory disorders of the ageing brain, for 
example. 
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Piezo1-mediated Ca2+ signalling in astrocytes 
Under non-inflammatory control conditions, cultured astrocytes appeared largely 
devoid of Piezo1 expression; although approximately 48% of cells responded to 
Yoda1 application with small influxes of calcium (Fig. 3A, B). Therefore, Piezo1 
channels may be expressed at low levels which are undetectable with the antibody 
used here. As a positive modulator of the Piezo1 ion channel, Yoda1 binds directly 
to Piezo1 to stabilize the open conformation of the channel pore, thus decreasing 
the threshold for mechanical activation (Cahalan et al., 2015; Syeda et al., 2015; 
Lacroix et al., 2018). However, Yoda1 may also exert some off-target effects, such 
as increasing the likelihood that other types of Ca2+-permeable channels will open, 
as suggested by Dela Paz & Frangos (2018) who showed that Yoda1 activates both 
Akt and ERK1/2 signalling in endothelial cell types, independent of Piezo1. The 
authors argue that Yoda1 may activate one or more transient receptor potential 
(TRP) cation channels which could explain how Akt and ERK1/2 become 
phosphorylated. This could also explain why, in our study, ~48% of control 
astrocytes responded to Yoda1 with small influxes of Ca2+, but we could detect only 
~3% of cells that expressed Piezo1 (as quantified by immunofluorescence). 
Following 24 h stimulation with LPS, however, Piezo1 was upregulated in ~25% 
of astrocytes and much larger Ca2+ influxes were observed (Fig. 3A). Moreover, 
60% of reactive astrocytes responded to Yoda1 versus 48% of control astrocytes 
(Fig. 3B). Therefore, the predominant component of the Yoda1-mediated Ca2+ 
response in reactive astrocytes is likely regulated by Piezo1 channels, even though 
a smaller off-target component is also detectable. 
 
Our data also demonstrate that Piezo1-mediated Ca2+ influx into LPS-stimulated 
astrocytes may trigger internal store-driven Ca2+ oscillations. In the absence of 
extracellular Ca2+, Yoda1 induced a net efflux of Ca2+ to the extracellular space of 
control astrocytes. In contrast, Yoda1 caused a net enhancement of cytosolic Ca2+ 
concentration in LPS-reactive astrocytes (Fig. 5A). Since Piezo1 expression is 
almost absent in control astrocytes, Yoda1-mediated efflux of Ca2+ may be caused 
by the non-specific opening of membrane-bound cation channels (e.g. TRP 
channels), thus allowing Ca2+ to flow out of the cell and into the Ca2+ and Mg2+ free 
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medium. LPS-reactive astrocytes, on the other hand, upregulate Piezo1 channels 
(Fig. 1) and given that Piezo1 can localise to the ER (Mc Hugh et al., 2010), our 
data suggests that Yoda1 triggers calcium release from internal stores, possibly via 
intracellular Piezo1 channels (Fig. 8). Moreover, depletion of Ca2+ from internal 
stores can activate calcium release-activated channels (CRAC) in the outer 
membrane, thus enhancing extracellular Ca2+ influx and facilitating the 
replenishment of internal calcium stores (Prakriya, 2009). Indeed, in the presence 
of extracellular Ca2+, we found that Yoda1 initially enhances cytosolic Ca2+ levels 
(most likely via Ca2+ influx through membrane-bound Piezo1 channels), which in 
turn has the potential to cause calcium-induced calcium release (CICR) from 
intracellular stores. CICR can also trigger further Ca2+ entry via membrane-
expressed store-operated calcium channels (SOCs), such as TRP cation channels, 
which are expressed both on the outer cell membrane as well as localised to the ER 
(Dong et al., 2010; Verkhratsky & Parpura, 2014). Taken together, this could 
explain why we observed more Ca2+ influx 2 – 4 min post-Yoda1 exposure versus 
the first 2 min of Yoda1 treatment (Fig. 3A). 
 
Piezo1 and ATP-responsiveness in astrocytes 
Prior activation of Piezo1, with Yoda1, decreased Ca2+ influx in response to ATP 
stimulation. This suggests that Piezo1 activation in reactive astrocytes could have 
both local and long-range consequences for neurotransmission in the cerebral 
cortex. Indeed, paracrine signalling in astrocyte networks is facilitated through 
ATP-mediated upregulation of inositol trisphosphate (IP3) which triggers the 
release of Ca2+ from internal stores (Fumagalli et al., 2003; Kastritsis, Salm, & 
McCarthy, 1992), and this, in turn, causes the release of more ATP from the 
astrocyte. ATP released from astrocytes can activate purinergic (P2X) receptors on 
the post-synaptic neuron and induce metaplastic changes in synaptic strength 
(Boue-Grabot & Pankratov, 2017). Bi-directional modulation of glutamatergic 
synaptic transmission has been demonstrated through either slow and prolonged 
decreases in AMPA receptor-mediated mini excitatory post-synaptic currents 
(mEPSCs) (Pougnet et al., 2014) or via P2X-mediated insertion of AMPA receptors 
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into the post-synaptic membrane which culminates in the long-term enhancement 
of mEPSC amplitude (Gordon et al., 2005). 
 
ATP is also important in the propagation of Ca2+ waves through astrocyte networks 
(Fujii, Maekawa, & Morita, 2017). Moreover, vasoactive substance release is 
regulated by astrocytic Ca2+ waves and ATP-induced Ca2+ release from intracellular 
stores within astrocytes (Metea & Newman, 2006). Therefore, astrocyte branches 
release factors that can induce vasoconstriction or vasodilation of cerebral 
vasculature (Filosa & Iddings, 2013). Piezo1-mediated dampening of ATP-induced 
Ca2+ waves in astrocytes could, in theory, regulate cerebral blood flow. Indeed, 
Piezo1 is activated by shear stress which leads to increases in nitric oxide synthase 
and NO release from vasculature-derived endothelial cells (Wang et al., 2016). 
Since astrocytic endfeet are in contact with pericytes that wrap around cerebral 
blood vessels (Abbott, Ronnback, & Hansson, 2006; Bonkowski, Katyshev, 
Balabanov, Borisov, & Dore-Duffy, 2011), it would be interesting to study the role 
of astrocytic Piezo1 in the regulation of vascular tone and blood brain barrier 
permeability in future experiments. 
 
Piezo1 and neuroinflammation 
Because astrocytes are also an important source of neuromodulatory cytokine and 
chemokine production post-LPS exposure (Lieberman, Pitha, Shin, & Shin, 1989; 
Rothhammer & Quintana, 2015), we measured the effects of Piezo1 activation on 
IL-1β, TNFα, IL-6 and CX3CL1 release from reactive astrocytes. Blocking Piezo1 
channels, using GsMTx4, had little or no effect on cytokine release. However, 
activating Piezo1 channels with Yoda1 significantly decreased pro-inflammatory 
cytokine release from LPS-stimulated cortical astrocytes. We also found that Yoda1 
decreased CX3CL1 release from unstimulated control astrocytes (Fig. 7D). 
Therefore, the anti-inflammatory effects of Yoda1 may not be entirely dependent 
on Piezo1 activation. Yoda1 may cause a general dampening of cytokine secretory 
activity in astrocytes.  
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Although LPS-induced up-regulation of Piezo1 in cultured astrocytes is somewhat 
transient (Fig. 1), with protein levels decreasing again after 48 h; chronic 
overexpression of Piezo1 does occur in vivo, particularly in reactive astrocytes 
surrounding amyloid plaques in the ageing brain of Alzheimer’s disease (AD) rats 
harbouring a chronic urinary tract infection (Velasco-Estevez et al., 2018). It is 
interesting to speculate on the potential functional roles of Piezo1, as well as the 
potential triggers of mechanosensitive channel opening, in the ageing and 
neurodegenerating brain (Tyler, 2012). We hypothesise that stiff amyloid plaques 
scattered randomly throughout the AD brain act as extrinsic mechanical modulators 
of Piezo1 channel opening probability. In addition, Piezo1 activity may be 
modulated by the gradual softening of ageing AD brain tissue (ElSheikh et al., 
2017) which also undergoes extracellular matrix (ECM) remodelling at sub-cellular 
length scales (Sethi & Zaia, 2017). Moreover, because amyloid plaques represent 
an altered extrinsic mechanical environment for astrocytes in vivo, Piezo1 ion 
channels could potentially modulate mechanotransduction signalling in reactive 
astrocytes in response to amyloid accumulation. Interestingly, Piezo1 regulates the 
expression of the mechanoresponsive transcriptional cofactor Yes-associated 
protein (YAP) and activates the Hippo signalling pathway (Pathak et al., 2014) 
which controls important processes such as cell contact inhibition and cell 
proliferation (Pavel et al., 2018). YAP is highly expressed by astrocytes and can 
activate suppressor of cytokine signalling (SOCS), thus preventing astrocyte 
reactivity by downregulating the JAK–STAT inflammatory pathway (Huang et al., 
2016). It will be important in future experiments to investigate the potential anti-
inflammatory mechanism of action of astrocytic Piezo1 in more detail and to 
determine if Piezo1 could be a novel drug target for neuroinflammatory disorders 
of the ageing brain. 
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Conclusion 
The data presented here suggests that mechanosensitive astrocytes upregulate 
Piezo1 channels in response to LPS in an attempt to inhibit pro-inflammatory 
cytokine release and dampen neuroinflammation. Activation of Piezo1 channels 
with Yoda1 slowed astrocyte migration and blocked TNFα, IL-1β and CX3CL1 
release from LPS-stimulated astrocytes. This is likely through Ca2+-dependent 
signalling cascades since Piezo1 activation enhanced both extracellular Ca2+ influx 
and internal store-mediated release of Ca2+ into the cytosol of reactive astrocytes. 
Moreover, Piezo1-mediated Ca2+ influx dampens subsequent ATP-induced Ca2+ 
responses in astrocytes, suggesting that Piezo1 could modulate neurotransmission 
by regulating gliotransmitter release at the synapse. It will be important, going 
forward, to investigate if there is a link between Ca2+-mediated 
mechanotransduction in astrocytes and other well-known biochemical signalling 
pathways that regulate synaptic plasticity, particularly in the ageing 
neuroinflammatory brain.  
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Figure 1: Lipopolysaccharide induces Piezo1 expression in astrocytes. Mouse cortical 
astrocytes were treated with 100 ng/mL LPS for 16, 24 or 48 h and then immunofluorescently 
labelled for (A) Piezo1 channels, (B) the astrocytic marker GFAP, and (C) nuclei were 
counterstained with DAPI. (D) Image represents the above three channels merged. Scale bar = 
20 µm. (E) LPS caused an upregulation of Piezo1 in astrocytes after 24 h, measured as an 
increase in Piezo1 fluorescence intensity co-localised with GFAP. (F) Only 2 – 3% of astrocytes 
expressed detectable levels of Piezo1 in control non-treated cultures. However, this rose to 
~15% after 16 h LPS and peaked at 20 – 25% of Piezo1-positive astrocytes following 24 h LPS 
exposure. Immunofluorescence experiments were repeated n = 5 with two technical replicates 
per experiment. Results are displayed as mean ± S.E.M and were analysed using a one-way 
ANOVA with Holm-Sidak post hoc test, * p < 0.05. (G) Results obtained through 
immunofluorescence were confirmed by Western blot (n = 3) where a detectable increase in 
Piezo1 protein (~286 kDa band) was observed in astrocytes after 24 h LPS exposure. (H) 
Upregulation of astrocytic Piezo1 24 h post-LPS exposure was further confirmed by PCR 
analysis of mRNA transcript levels. PCR experiments were repeated n = 5 with two technical 
replicates per experiment. Results are displayed as fold change from control levels and were 
analysed using a paired Student’s T test, * p < 0.05. 
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Figure 2: Activation of Piezo1 increases 
intracellular calcium in LPS-reactive 
astrocytes.  Astrocytes were pre-treated 
with or without LPS (100 ng/mL) for 24 h 
and loaded with Cal-520AM calcium 
indicator for 2 h in Hank’s balanced salt 
solution (HBSS) containing calcium (Ca2+) 
and magnesium (Mg2+). Immediately prior 
to Ca2+ imaging experiments, astrocytes 
were transferred to fresh HBSS with Ca2+ 
and Mg2+ (i.e. Extracellular Ca2+ group). 
(A) Representative confocal images (20× 
magnification) of baseline Ca2+ levels and 
Ca2+ influx in response to HBSS, Yoda1 
and ATP in control and reactive astrocytes 
pre-treated with LPS for 24 h. The 
rainbow-coloured palette represents 
intracellular Ca2+ concentrations with dark 
purple/black signifying low levels of Ca2+ 
and yellow/red representing high levels of 
Ca2+. Scale bar = 100 µm. The maximum 
intensity projections of all 349 images were 
used to segment astrocytes and delineate 
the nuclear and cytosolic compartments of 
each individual cell. All data are presented 
as changes in cytosolic Ca2+ influx as 
opposed to changes in nuclear Ca2+ 
concentrations. Time-lapse Ca2+ imaging 
experiments were performed at a rate of 
0.77 frames per second over a 7 min 30 s 
period (i.e. 349 images in total), which included 30 s baseline, 4 min exposure to 10 µM Yoda1 
or fresh HBSS, followed by stimulation with 50 µM ATP for 3 min. (B) Representative traces 
showing changes in cytosolic Ca2+ levels in control and (C) LPS-stimulated astrocytes in 
response to HBSS (black) and Yoda1 (blue). There was a 30 s baseline, at which point HBSS 
or Yoda1 was perfused onto astrocyte cultures for 4 min followed by ATP stimulation (at 270 
s) for a further 3 min. Yoda1 caused larger elevations in cytosolic Ca2+ in LPS-treated astrocytes 
compared to control non-reactive astrocytes. 
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Figure 3: Activation of Piezo1 increases calcium oscillations in LPS-stimulated astrocytes. 
(A) HBSS was used as a control for extracellular medium perfusion because Piezo1 channels 
are mechanosensitive and can be activated by shear stress. However, HBSS did not induce any 
appreciable increase in Ca2+ influx into control or LPS-stimulated astrocytes. Yoda1, on the 
contrary, caused an increase in Ca2+ influx into control astrocytes and a significantly larger 
influx of Ca2+ into LPS-stimulated astrocytes (+48.3 [-3.2, +158.1 IQR] vs +96.3 [37.5, 200.0 
IQR] arbitrary fluorescence units; a.f.u). Data are presented as median ± interquartile range and 
were analysed using a two-way ANOVA with Bonferroni post hoc test, * p < 0.05. The first 2 
min of HBSS/Yoda1 exposure (designated “early”) was also analysed separately to the last 2 
min (“late”). In general, there was more Ca2+ influx in the latter 2 min period than the first 2 
min, both in control and LPS-treated astrocytes, suggesting a delayed and prolonged increase 
in cellular Ca2+ levels in response to Yoda1 and, hence, Piezo1 channel activation. Early- and 
late-phase Yoda1 exposure data are presented as mean ± the standard error of the mean (S.E.M). 
(B) Approximately 9 – 10% of control astrocytes stimulated with either HBSS or Yoda1, and 
LPS-stimulated astrocytes perfused with HBSS, displayed 2 or more Ca2+ peaks (i.e. Ca2+ 
oscillations). Interestingly, LPS-treated astrocytes stimulated with Yoda1 displayed double the 
number of cells expressing Ca2+ oscillations (i.e. 20%), χ2 test, p < 0.001. This suggests that 
upregulation of Piezo1 in LPS-treated astrocytes may promote oscillatory Ca2+ activity in 
response to mechanical stimuli. (C) However, Yoda1-stimulated astrocytes responded less to 
ATP perfusion compared to HBSS-stimulated cells. Both the amplitude and the area under the 
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curve (AUC) of the Ca2+ response to ATP was significantly reduced in Yoda1-stimulated 
astrocytes. Data are presented as median ± interquartile range and were analysed using a two-
way ANOVA with Bonferroni post hoc test, * p < 0.05. Astrocytes pre-treated with LPS for 24 
h showed the largest AUC and peak amplitude to ATP, suggesting reactive astrocytes are more 
responsive to purinergic receptor stimulation. (D) However, only 26% of reactive astrocytes 
stimulated with Yoda1 displayed Ca2+ oscillations to ATP, whereas 36–45% of cells in the other 
three groups displayed ATP-induced Ca2+ oscillations. Therefore, Yoda1-mediated activation 
of Piezo1 appeared to dampen ATP-induced Ca2+ oscillations in astrocytes, χ2 test, p < 0.001. 
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Figure 4: Activation of Piezo1 increases 
calcium release from intracellular stores 
in LPS-reactive astrocytes.  Time-lapse 
Ca2+ imaging experiments were repeated in 
astrocyte cultures in the absence of 
extracellular calcium and magnesium (i.e. 
HBSS minus Ca2+ and Mg2+) in order to 
assess intracellular store-driven Ca2+ fluxes 
regulated by Piezo1 channels. Astrocytes 
were pre-treated with or without LPS (100 
ng/mL) for 24 h and loaded with Cal-
520AM calcium indicator for 2 h in Hank’s 
balanced salt solution (HBSS) containing 
calcium (Ca2+) and magnesium (Mg2+). 
Immediately prior to Ca2+ imaging 
experiments, astrocytes were transferred to 
fresh HBSS-/- without Ca2+ and Mg2+ (i.e. 
Intracellular Ca2+ group). (A) 
Representative confocal fluorescence 
images of astrocytes loaded with Cal-
520AM dye and stimulated with HBSS-/-, 
Yoda1-/- and ATP-/-. The rainbow-coloured 
palette describes low versus high levels of 
intracellular Ca2+ concentrations. Scale bar 
= 100 µm. (B) Representative traces of 
control and (C) LPS-treated astrocytes 
stimulated with HBSS-/- or Yoda1-/- and 
ATP-/- in the absence of extracellular Ca2+ 
and Mg2+. Yoda1 caused a decrease in 
intracellular Ca2+ levels in control 
astrocytes, possibly through depletion of intracellular stores and efflux of Ca2+ from the cytosol. 
However, Yoda1-/- caused an increase in internal store-mediated Ca2+ elevations in LPS reactive 
astrocytes. 
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Figure 5: Yoda1 decreases ATP-induced calcium oscillations in astrocytes. (A) In control 
astrocytes, Yoda1 caused an efflux of Ca2+ from the cytosol to the extracellular space resulting 
in a decrease in Cal-520AM fluorescence intensity. In reactive astrocytes pre-treated with LPS 
for 24 h, however, Yoda1 caused increases in cytosolic Ca2+ levels, presumably through release 
from intracellular stores but with a reduced efflux of Ca2+ ions to the extracellular space. Data 
for the total 4 min treatment period are represented as the median ± the interquartile range and 
were analysed using a two-way ANOVA with Bonferroni post hoc test, * p < 0.05. The “early” 
and “late” phase data represent the mean ± S.E.M. (B) Control astrocytes bathed in HBSS minus 
Ca2+ and Mg2+ and stimulated with Yoda1 displayed the lowest proportion of cells responding 
with multiple Ca2+ oscillations (21%). This was due to the large efflux of Ca2+ in response to 
Yoda1. However, reactive astrocytes stimulated with Yoda1 displayed the largest proportion of 
intracellular store-driven Ca2+ oscillations (53%), χ2 test, p = 0.008. (C) Interestingly, control 
astrocytes bathed in HBSS minus Ca2+ and Mg2+ and stimulated with Yoda1 showed the highest 
Ca2+ response to ATP, both in peak amplitude and AUC. This is likely due to the very low 
levels of cytosolic Ca2+ post-Yoda1 stimulation, i.e. the relative increases in Ca2+ appear very 
high when the basal levels are low. (D) Moreover, Yoda1 decreased the percentage of control 
cells that displayed ATP-induced store-driven Ca2+ oscillations (24%), χ2 test, p < 0.001, 
suggesting that when basal Ca2+ levels are low, purinergic receptor stimulation does not induce 
many store-driven Ca2+ oscillations. 
32 | P a g e  
 
 
 
Figure 6: Piezo1 channels modulate astrocyte migration (A) Astrocyte cultures were treated 
with the Piezo1 agonist, Yoda1 (10 µM), or the blocking peptide, GsMTx4 (500 nM), in the 
presence or absence of LPS (100 ng/mL) for 48 h. Neither Yoda1 nor GsMTx4 significantly 
affected cell viability of control or LPS-stimulated astrocytes as measured by the MTT assay. 
Data are presented as a percentage of the mean control fluorescence intensity (540/590 nm) ± 
S.E.M from n = 6 independent experiments. Results were analysed using a 2-way ANOVA with 
the Holm-Sidak post hoc test. (B) To confirm that Piezo1 activation with Yoda1 had negligible 
effects on cellular stress, the JC-1 assay was performed to measure levels of mitochondrial 
stress in control and LPS-stimulated astrocytes. Neither Yoda1 nor GsMTx4 caused significant 
mitochondrial stress in LPS-treated astrocyte cultures. Data are presented as the mean 
absorbance levels (at 570 nm) ± S.E.M normalised to control values (n = 6 independent 
experiments). Results were analysed using a 2-way ANOVA with the Holm-Sidak post hoc 
test.  (C) Next, a ‘wound healing’ type cell migration assay was performed to assess changes 
in the speed of astrocyte migration in response to Piezo1 activation and inhibition. Activation 
of Piezo1 with Yoda1 did not significantly affect astrocyte migratory velocity in control (2.0 ± 
0.4 vs 3.3 ± 1.0 µm/h) or LPS-stimulated cultures (1.4 ± 0.5 vs 2.3 ± 0.3 µm/h). Similarly, 
inhibition of Piezo1 with GsMTx4 did not alter astrocyte migration velocity in control (3.8 ± 
0.6 vs 3.3 ± 1.0 µm/h) or LPS-stimulated cultures (5.0 ± 0.9 vs 2.3 ± 0.3 µm/h). However, there 
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were significant differences in the velocities of LPS-stimulated astrocytes exposed to Yoda1 
versus GsMTx4 (1.4 ± 0.5 vs 5.0 ± 0.9 µm/h), suggesting that Piezo1 channel activation in 
reactive astrocytes inhibits the speed of collective cell migration. Data are presented as the mean 
distance travelled (µm) in 48 h (black horizontal line), interquartile range (shaded rectangle) 
and the absolute distance values of n = 6 independent experiments. Differences were analysed 
using a 2-way ANOVA with the Holm-Sidak post hoc test and * p < 0.05.  (D) and (E) are 
representative images of the migration assay showing (D) control and (E) LPS-stimulated 
astrocytes after 48 h treatment with GsMTx4. Scale bar = 100 µm. 
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Figure 7: Piezo1 channels modulate cytokine and chemokine release from astrocytes. (A) 
Cytokine and chemokine release from control and LPS-stimulated astrocytes were measured 
after 48 h of either Yoda1 or GsMTx4 exposure. GsMTx4 peptide (500 nM) had little or no 
effect on cytokine release from reactive astrocytes. However, LPS-stimulated astrocytes 
exposed to 10 µM Yoda1 for 48 h showed a significant decrease in (A) TNFα and (B) IL-1β 
release into the cell culture medium, as measured by ELISA. (C) Yoda1 did not cause a 
significant reduction in IL-6 release from astrocytes when compared to the LPS only group 
(4,274 ± 601 vs 6,468 ± 1,202 pg/mL), but levels of IL-6 release in the LPS/Yoda1 group were 
significantly less than the LPS/GsMTx4-treated astrocytes (8,076 ± 947 pg/mL). (D) Yoda1 
also caused a significant decrease in CX3CL1 release from both control (3,105 ± 94 vs 10,140 
± 741 pg/mL) and LPS-stimulated astrocytes (4,089 ± 430 vs 11,745 ± 1,210 pg/mL). Data 
from the ELISA assays are presented as mean ± S.E.M. TNFα, IL-1β and IL-6 ELISA’s were 
repeated n = 5 and CX3CL1 ELISA was repeated n = 3. Differences were analysed using a 2-
way ANOVA with the Holm-Sidak post hoc test and * p < 0.05.  
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Figure 8: Proposed mechanism to explain Piezo1-mediated anti-inflammatory effects in 
LPS-stimulated astrocytes. Primary cortical astrocytes treated for 24 h with LPS upregulate 
Piezo1 expression. Activating Piezo1 channels with Yoda1 causes calcium (Ca2+) influx and 
increases intracellular store-driven Ca2+ oscillations. In addition to its expression at the outer 
cell membrane, Piezo1 may localise to the endoplasmic reticulum (ER) of reactive astrocytes, 
thus enhancing intracellular Ca2+ release following Yoda1 exposure. Indeed, Syeda et al. (2015) 
have also reported that chelation of extracellular Ca2+ with EGTA did not completely abolish 
the calcium responses observed in HEK293T cells following Yoda1 stimulation. Alternatively, 
Yoda1 may also induce non-specific effects independent of Piezo1. In the absence of 
extracellular Ca2+, Yoda1 triggered release of Ca2+ from intracellular stores in reactive 
astrocytes (Fig. 5A) and increased Ca2+ oscillations compared to Yoda1-stimulated control 
astrocytes (Fig. 5B). Yoda1 also decreased IL-1β, TNFα and CX3CL1 release from LPS-
stimulated astrocytes, suggesting that Piezo1 may play a role in dampening neuroinflammation 
in the brain. More work is needed to investigate if there is a link between Piezo1-mediated Ca2+ 
oscillations, reduced ATP-responsiveness and inhibition of pro-inflammatory cytokine release 
from reactive astrocytes.  
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